Cara Therapeutics (CARA) Tops Q1 EPS by 1c
Get Alerts CARA Hot Sheet
Join SI Premium – FREE
Cara Therapeutics (NASDAQ: CARA) reported Q1 EPS of ($0.39), $0.01 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Cara Therapeutics (CARA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Super Micro Computer (SMCI) Falls 6%
- Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!